Rossari Biotech has informed that the Board of Directors have approved Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022 of the Financial Year 2021-22 and other matters.
The above information is a part of company’s filings submitted to BSE.